Daniel Kreisel MD PhD
Cardiovascular Surgery
Professor, Surgery, Pathology & Immunology, Surgical Director, Lung Transplant Program, Washington University School of Medicine
Join to View Full Profile
1 Barnes Jewish Hospital Plz# DivSaint Louis, MO 63110
Phone+1 314-362-7260
Fax+1 314-362-6288
Dr. Kreisel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Thoracic Surgery - Independent, 2003 - 2005
University of Pennsylvania Health SystemResidency, Surgery, 1995 - 2003
Icahn School of Medicine at Mount SinaiClass of 1995
Certifications & Licensure
MO State Medical License 2005 - 2026
PA State Medical License 1996 - 2006
American Board of Surgery Surgery
American Board of Thoracic Surgery Thoracic and Cardiac Surgery
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2012
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Utility of Routine Cervical Mediastinoscopy in Clinical Stage I Non-Small Cell Lung Cancer (NSCLC) Start of enrollment: 2008 Jan 01
- Novel Lung Trial: Normothermic Ex Vivo Lung Perfusion (Evlp) As An Assessment Of Extended/Marginal Donor Lungs Start of enrollment: 2011 May 01
- Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 3 citationsDeveloping approaches to incorporate donor-lung computed tomography images into machine learning models to predict severe primary graft dysfunction after lung transpla...Weiwei Ma, Inez Oh, Yixuan Luo, Sayantan Kumar, Aditi Gupta
American Journal of Transplantation. 2025-06-01 - Maintenance of graft tissue-resident Foxp3+ cells is necessary for lung transplant tolerance in mice.Wenjun Li, Yuriko Terada, Yun Zhu Bai, Yuhei Yokoyama, Hailey M Shepherd
The Journal of Clinical Investigation. 2025-05-15 - 1 citationsAcute kidney injury triggers hypoxemia by lung intravascular neutrophil retention that reduces capillary blood flow.Yohei Komaru, Liang Ning, Carine Lama, Anusha Suresh, Eirini Kefaloyianni
The Journal of Clinical Investigation. 2025-05-15
Journal Articles
- Neutrophil Extracellular Trap Fragments Stimulate Innate Immune Responses That Prevent Lung Transplant ToleranceDaniel Kreisel, Yizhan Guo, Alexander S Krupnick, American journal of transplantation
- Bronchiolitis-Obliterans Syndrome-Free Survival Following Lung Transplantation - an International Society for Heart and Lung Transplantation (ISHLT) Thoracic Transplan...Daniel E Kreisel, Varun Puri, Benjamin D Kozower, G Alec Patterson, The Journal of Heart and Lung Transplantation
- The Human Heart Contains Distinct Macrophage Subsets with Divergent Origins and FunctionsDaniel Kreisel, Stavros G Drakos, Kory J Lavine, Craig H Selzman, Nature
Authored Content
- Bronchiolitis-Obliterans Syndrome-Free Survival Following Lung Transplantation - an International Society for Heart and Lung Transplantation (ISHLT) Thoracic Transplant Registry AnalysisSeptember 2018
Press Mentions
Researchers Receive $22 Million Grant for Clinical Trial That Aims to Reduce Lung Transplant RejectionNovember 18th, 2021- NIH Grants $10M to Study Immune Cells’ Role in Lung, Heart Transplant RejectionSeptember 4th, 2020
- $10 Million in Grants Aimed at Preventing Organ Rejection After TransplantationSeptember 1st, 2020
- Join now to see all
Grant Support
- The Role of Ischemia Reperfusion Injury in Lung Allograft RejectionWASHINGTON UNIVERSITY2009–2030
- Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With ClazakizumabMASSACHUSETTS GENERAL HOSPITAL2021–2028
- Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With ClazakizumabMASSACHUSETTS GENERAL HOSPITAL2021–2028
- Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With ClazakizumabMASSACHUSETTS GENERAL HOSPITAL2021–2028
- Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With ClazakizumabMASSACHUSETTS GENERAL HOSPITAL2021–2028
- Leukocyte trafficking in thoracic graftsST. LOUIS VA MEDICAL CENTER2022–2025
- Leukocyte trafficking in thoracic graftsST. LOUIS VA MEDICAL CENTER2022–2025
- Leukocyte trafficking in thoracic graftsST. LOUIS VA MEDICAL CENTER2022–2025
- Leukocyte trafficking in thoracic graftsST. LOUIS VA MEDICAL CENTER2022–2025
- Leukocyte trafficking in thoracic graftsST. LOUIS VA MEDICAL CENTER2022–2025
- Leukocyte trafficking in thoracic graftsST. LOUIS VA MEDICAL CENTER2022–2025
- Leukocyte trafficking in thoracic graftsST. LOUIS VA MEDICAL CENTER2022–2025
- Leukocyte trafficking in thoracic graftsST. LOUIS VA MEDICAL CENTER2022–2025
- The Role of Donor Innate Immune Responses in Regulating Alloimmunity after Heart TransplantationWASHINGTON UNIVERSITY2020–2025
- Pathways Regulating Lung Transplant Tolerance.WASHINGTON UNIVERSITY2015–2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
